TBPN — $2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

SCOUT· 63%2h 39m·2026-03-27·Technology

$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

TBPN · 457

Sign up for TBPN’s daily newsletter at TBPN.com (01:53) - Novartis to Buy Excellergy for $2B (11:04) - 𝕏 Timeline Reactions (24:08) - Anthropic Stories (33:06) - Mansion Section (54:23) - Billy Boman, an AI visual creator and educator, discusses his journey from a creative upbringing and formal design education to…

Listen now

Buzzmeter · cross-platform

63%

SCOUT

Scout bees are checking it out — divided opinions, the swarm hasn't committed.

Hive Vote · Skep listeners

New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Recent reviews

No reviews yet — be the first.

$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

Rate this episode

More from TBPN

Astra Ends Math, 1 Person $1M Companies, Hank Green Is Absolutely Right | John Gruber, Shaun Maguire & Isaiah Taylor, Justin Lopas, Beau Gaston, Ron Arel

GPT-5.6 Sol Reactions, Coatue Bets Big on Blue Origin, Cheaper Vision Pro Delayed | Vincent Weisser, Ben Thompson, Rodrigo Liang, Alana Palmedo, Byron Boots, Will Mayer, Tucker Brown

XBOX Layoffs, "Manual" Ferrari, Circle K Lottery Dispute | Baiju Bhatt, Daniel English, Michele Catasta